The most common cause is genetic, although doctors suspect that insulin resistance or hyperandrogenemia may also be contributing factors. There are no proven ways to prevent or treat endometrial cancer. However, patients suffering from this condition should consider undergoing regular screenings to reduce the risk of developing the disease. However, early detection is essential to ensuring that a positive diagnosis is made.
During the reproductive years, women should consult their doctor to rule out other causes of irregular menstrual periods, such as intrauterine pregnancy or ectopic pregnancy. Also, women must discuss the risks and benefits of estrogen and progestin. Contraceptive pill use may reduce the risk of endometrial cancer in women, but it comes with its own set of side effects. Women should discuss the pros and cons of hormone therapy with their doctor before starting treatment.
The main differences between LG-ESS and HG-ESS are in their type of metastatic spread and the type of initial surgery. LG-ESS are intrauterine lesions that are localized but may develop lymphatic metastases, which worsen the patient’s prognosis. YWHAE-FAM22-positive ESS have a poor prognosis, but patients with LG-ESS may have an aggressive UUS.
In addition to cancer of the endometrium, there are also two types of uterine cancer. Uterine sarcoma is a type of soft tissue sarcoma that develops in the muscle wall of the uterus. And the third type is uterine cancer known as uterine carcinosarcoma. These cancer cells resemble a combination of endometrial adenocarcinoma and sarcoma. Most cases of endometrial cancer occur in older women, but the number is growing.
Other risks of endometrial cancer include irregular ovulation and menstrual cycles, obesity, and diabetes. In addition, high-dose radiation from pelvic tumors is associated with an increased risk of endometrial cancer. Taking hormone therapy for breast cancer, such as Tamoxifen, increases the risk of endometrial cancer, but the benefits outweigh the small risk. It is important to note, however, that the risks are minimal compared to the benefits.
The most common types of endometrial cancer are type 1, grades 1 and 2 and grade 3 endometrioid carcinoma. High-grade endometrial cancer is classified as grade 3 and is associated with a poor prognosis. Type two endometrial cancer is more aggressive, often involving lymphatic invasion and metastases. It is important to remember that the prognosis of these cancers depends on the stage at which the cancer first appears.
Top experts in endometrial cancer evaluate each patient individually to find the best treatment option. They use cutting-edge technology and a leading endometrial cancer research program in the United States to help patients manage the disease. They work with patients’ treatment teams, and specially trained staff provide support. And they can help patients overcome the emotional and psychological challenges associated with endometrial cancer. There are numerous treatment options for this disease, but there is no definite cure.
